¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ȯ"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 14 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • conversion rate
    ÀüȯÀ²
  • conversion reaction
    Àüȯ¹ÝÀÀ
  • convertase
    Àüȯȿ¼Ò
  • converter
    Àüȯ±â
  • converting enzyme inhibitor
    Àüȯȿ¼Ò¾ïÁ¦Á¦
  • coronary circulation
    °ü»óµ¿¸Æ¼øÈ¯, ½ÉÀ嵿¸Æ¼øÈ¯
  • coronary steal
    °ü»óµ¿¸Æ½ºÆ¿, ½ÉÀåÇ÷·ùÀüȯ
  • cardiac
    1. ½ÉÀå- 2. µé¹®-, ºÐ¹®- 3. ½ÉÀ庴ȯÀÚ
  • countercurrent exchange
    ¿ª·ù±³È¯
  • cremaster muscle
    °íȯ¿Ã¸²±Ù, °íȯ°Å±Ù
  • cremasteric artery
    °íȯ¿Ã¸²±Ùµ¿¸Æ, °íȯ°Å±Ùµ¿¸Æ
  • cremasteric fascia
    °íȯ¿Ã¸²±Ù¸·, °íȯ°Å±Ù¸·
  • cremasteric reflex
    °íȯ¿Ã¸²±Ù¹Ý»ç, °íȯ°Å±Ù¹Ý»ç
  • cretin
    Å©·¹Æ¾º´È¯ÀÚ
  • critical care medicine
    ÁßȯÀÚÄ¡·áÀÇÇÐ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • transducer
    º¯È¯±â, ŽÃËÀÚ
  • transsexualism
    ¼ºÀüȯÁõ
  • testis
    °íȯ
  • testicular
    °íȯ-
  • turnover
    ȸÀü, ¹ÝÀü, Àüȯ
  • tunica vaginalis
    °íȯÁý¸·
  • ectopic testis
    µý°÷°íȯ(Áõ)
  • exchange transfusion
    ±³È¯¼öÇ÷
  • malignant transformation
    ¾Ç¼º¼¼Æ÷Àüȯ
  • metabolic turnover
    ´ë»çÀüȯ
  • substitution transfusion
    (¢¡exchange transfusion) ±³È¯¼öÇ÷
  • testicular torsion
    °íȯ²¿ÀÓ
  • torsion testis
    (¢¡testicular torsion) °íȯ²¿ÀÓ
  • undescended testis
    ¾È³»·Á°£°íȯ, ¹ÌÇϰ­°íȯ, ¹è¾È°íȯ
  • venting
    ¹è±â, ȯ±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • case finding program
    ȯÀڹ߰߰èȹ, ȯÀڹ߰߻ç¾÷
  • spot map
    ȯÀڹ߻ýÁöµµ
  • spot mapping
    ȯÀڹ߻ýÁöµµÀÛ¼º
  • air ambulance
    ȯÀÚ¼ö¼ÛºñÇà±â
  • sickrole behavior
    ȯÀÚ¿ªÇÒÇàÅÂ
  • stretcher
    ȯÀÚ¿î¹ÝÂ÷, µé°Í, ½ÅÀå±â
  • patient positioning
    ȯÀÚÀ§Ä¡°áÁ¤
  • patient triggered respirator
    ȯÀÚÀ¯¹ß½ÄÀΰøÈ£Èí±â
  • patient triggered ventilator
    ȯÀÚÀ¯¹ßÈ£Èí±â
  • patient identification
    ȯÀÚÈ®ÀÎ
  • phantom limb sensation
    ȯÁö°¨, ȯ»óÆÈ´Ù¸®°¨°¢
  • phantom limb pain
    ȯÁöÅë, ȯ»óÆÈ´Ù¸®ÅëÁõ
  • auditory hallucination
    ȯû, µè±âȯ°¢
  • auditory hallucinosis
    ȯûÁõ, ¼Ò¸®È¯°¢Áõ
  • tactile hallucination
    ȯÃË, Ã˰¢È¯°¢
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • circular insanity
    ¼øÈ¯Á¤½ÅÀÌ»ó
  • circular reaction
    ¼øÈ¯¹ÝÀÀ
  • circulating blood volume
    ¼øÈ¯Ç÷¾×·®
  • circulatory collapse
    ¼øÈ¯ÇãÅ»
  • circulatory congestion
    ¼øÈ¯¿ïÇ÷
  • circulatory diffusion
    ¼øÈ¯È®»ê
  • circulatory failure
    ¼øÈ¯±â´É»ó½Ç, ¼øÈ¯ºÎÀü
  • circulatory shock
    ¼øÈ¯¼îÅ©
  • circulatory system
    ¼øÈ¯°èÅë
  • class switch
    Ŭ·¡½ºÀüȯ
  • collar crown
    ´ëȯÀÇÄ¡°ü, Ä®¶ó°ü
  • collateral circulation
    °ç¼øÈ¯
  • command hallucination
    ¸í·Éȯ°¢
  • commitment index
    ³»¿øÈ¯ÀÚÁö¿ªº°±¸¼ºµµ
  • community setting
    Áö¿ª»çȸȯ°æ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • alveolar gas exchange
    ÆóÆ÷±âü±³È¯(¡­Îß üµ)
  • alveolar gas exchange
    ÆóÆ÷°¡½º±³È¯(¡­Îß üµ).
  • alveolar hypoventilation
    ÆóÆ÷Àúȯ±â(¡­î¸üµÑ¨).
  • alveolar hypoventilation syndrome
    ÆóÆ÷Àúȯ±âÁõÈıº.
  • alveolar ventilation
    ÆóÆ÷ȯ±â(·®)
  • alveolar ventilation rate
    ÆóÆ÷ȯ±âºñ(¡­üµÑ¨Ýï)
  • alveolar ventilation volume
    ÆóÆ÷ȯ±â¿ëÀû
  • analog to digital converter
    ¾Æ³ª·Î±× µðÁöÅ» º¯È¯±â
  • anchor band
    À¯Áö´ëȯ(ë«ò¥Óáü»).
  • anchor clamp band
    À¯Áö´ëȯ.
  • andersen disease
    ¾Ø´õ½¼º´<--Áúȯ>
  • anemia,myelophthisic
    °ñ¼öġȯ¼º(ÍéâÐöÇüµàõ) (ºóÇ÷)(Þ¸úì)
  • angiocardiology
    1. ½ÉÇ÷°üº´ÇÐ(ãýúìηܻ ùÊ). 2. ¼øÈ¯±âÇÐ(âàü»ÐïùÊ).
  • angiosis
    Ç÷°üÁúȯ(úìηòðü´).
  • angiospasmodic disease
    Ç÷°ü¿¬Ã༺ Áúȯ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • ventilatory
    ȯ±âÀÇ.
  • control of ventilation
    ȯ±âÁ¶Àý(Ì·Ë»Ì¡Ëø).
  • control of ventilation
    ȯ±âÁ¶Àý(üµÑ¨ðàï½).
  • ventilation index =VI
    ȯ±âÁö¼ö(Ì·Ë» ̤Ëà).
  • ventilatory support
    ȯ±âÁö¿ø(¡­ò¨êµ).
  • reducibility
    ȯ³³¼º(ü½Ò¡àõ), ȯ¿ø¼º (ü½êªàõ).
  • lantern test
    ȯµî½ÃÇè(ÊÙËàÌ´).
  • rheotrope
    ȯ·Î±â(üµÖØÐï).
  • reflux condenser
    ȯ·ù³Ã°¢±â(¡­ÕÒÊ¿Ðï).
  • gustatory hallucination
    ȯ¹Ì
  • gustatory hallucination See hallucination
    ȯ¹Ì(ü³Ú«).
  • hallucination, gustatory
    ȯ¹Ì(ü³Ú«).
  • reduced heat
    ȯ»ê¿­·®(üµß©æðåÖ).
  • reduced mass
    ȯ»êÁú·®(üµß©òõåÖ).
  • calibration scale
    ȯ»êÇ¥(üµß©øú)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • anomalies of systemic venous return
    ´ëÁ¤¸ÆÈ¯·ù(ÓÞð¡Øæü½êü)ÀÌ»ó.
  • anomalies of systemic venous return
    ´ëÁ¤¸ÆÈ¯·ù(ËÀ?ËÎÌ·Ëô)ÀÌ»ó.
  • anomalous pulmonary venous drainage
    ÆóÁ¤¸ÆÈ¯·ù(øËð¡Øæü½êü)ÀÌ»ó.
  • anomalous pulmonary venous drainage
    ÆóÁ¤¸ÆÈ¯·ù(̰?ËÎÌ·Ëô)ÀÌ»ó.
  • anomalous pulmonary venous return
    ÆóÁ¤¸ÆÈ¯·ùÀÌ»ó.
  • anorchi(di)sm
    ¹«°íȯÁõ(ÙíÍÂü¯ñø).
  • anorchia
    ¹«°íȯ
  • anorchia congenital
    ¼±Ãµ¼º ¹«°íȯÁõ.
  • anorchism
    °íȯ°á¿©Áõ
  • anterior atlanto-occipital membrane
    ¾ÕȯÃßÈĵθ·, ÀüȯÃßÈĵθ·(îñü» õÐý­Ô騝
  • anterior embryotoxon
    ¾ÕÅ»ýȯ
  • antigenic diversion
    Ç׿øÀüȯ(ù÷ê«ï®üµ).
  • antigenic transformation
    Ç׿øº¯È¯(ù÷ê«Ü¨üµ).
  • antihallucinogen
    Ç×ȯ°¢Á¦(ù÷ü³ÊÆð¥).
  • aortic configuration = sabot heart
    ´ëµ¿¸Æ(ÆÇ¸·Áúȯ) Çü»ó
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
  • morbidity r.
    ÀÌȯÀ²
    ìºü´ëÒ
  • conversion r.
    Àüȯ¹ÝÀÀ
    ï®üµÚãëë
  • reduction
    µÇ¸ÂÃã, ±³Á¤, ȯ¿ø, Ãà¼Ò
    Îìïá, ü½êª, õêá³
  • cremasteric r.
    °íȯ¿Ã¸²±Ù¹Ý»ç, °Å°í±Ù¹Ý»ç
    ËáÍÂÐÉÚãÞÒ
  • replacement
    ±³È¯, ´ëÄ¡, ġȯ
    Îßüµ, ÓÛöÇ, öÇüµ
  • reversion
    µÇ¤±â, Àüȯ
    ï®üµ
  • rotation
    ȸÀü, µ¹¸², ¼øÈ¯
    üÞï®, âàü»
  • circulatory s.
    ¼øÈ¯°è
    âàü»Í§÷Ö
  • transforming growth factor
    Àüȯ¼ºÀåÀÎÀÚ
    ï®üµà÷íþì×í­
  • transitional
    Àüȯ¼º
    ï®üµàõ
  • assist control v.
    º¸Á¶Á¶Àýȯ±â
    ÜÍð¾ðàï½üµÑ¨
  • control mode v.
    Á¶Àý¸ðµåȯ±â
    ðàクðµåüµÑ¨
  • intermittent mandatory v., IMV
    °£Çæ°­Á¦È¯±â
    ÊàúÎîÜË­ð¤üµÑ¨
  • intermittent positive-pressure v.
    °£Çæ¾ç¾Ðȯ±â
    ÊàúÎåÕäâüµÑ¨
  • mechanical v.
    ±â°èȯ±â
    ѦÌþîÜüµÑ¨
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • lysogenic conversion
    ¿ë¿øº¯È¯(éÁê«Ü¨üµ)
  • lysosomal disease
    ¶óÀ̼ÒÁ»Áúȯ(òðü´)
  • lysosomal storage disease
    ¶óÀ̼ÒÁ»³»(Ò®) ÀúÀåÁúȯ(îÍíúòðü´)
  • maple syrup urine disease
    ´Üdz½Ã·´´¢Áúȯ(Òãòðü´)
  • metabolic disease
    ´ë»çÁúȯ(ÓÛÞóòðü´)
  • metathesis
    »óÈ£±³È¯(ßÓû»Îßüµ)
  • microenvironment
    ¹Ì¼¼È¯°æ(Ú°á¬ü»ÌÑ)
  • milieu interieur
    ³»ºÎȯ°æ(Үݻü»ÌÑ)
  • mucopolysaccharide storage disease
    ¹ÂÄÚ´Ù´çÁú(ÒýÓØòõ)ÀúÀåÁúȯ(îÍíúòðü´)
  • Niemann-Pick disease
    ´Ï¸¸-ÇÈ Áúȯ(òðü´)
  • nitrate reduction
    Áú»êȯ¿ø(òòß«ü½êª)
  • nonpermissible substitution
    ºñÇã¿ë ġȯ(ÞªúÉé»öÇüµ)
  • nonreducing sugar
    ºñȯ¿ø´ç(Þªü½êªÓ×)
  • nucleophilic substitution
    ±¸ÇÙġȯ(Ï´ú·öÇüµ)
  • nucleotide exchange reaction
    ´©Å¬¸®¿ÀŸÀÌµå ±³È¯¹ÝÀÀ(ÎßüµÚãëë)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • neuromuscular disease
    ½Å°æ±ÙÀ° Áúȯ
  • obstructive pulmonary disease
    Æó¼â¼ºÆóÁúȯ
  • orchiditis
    °íȯ¿°
  • orchiectomy
    °íȯÀýÁ¦¼ú, Á¦°í¼ú
  • orchitis
    °íȯ¿°
  • pelvic inflammatory disease
    °ñ¹Ý¿°Áúȯ
  • peripheral vascular disease
    ¸»ÃÊÇ÷°üÁúȯ
  • phase frequency swap
    À§»óÁ֯ļö±³È¯
  • photosensitizer
    ±¤°ú¹ÎȯÀÚ
  • polycystic disease
    ´Ù³¶¼ºÁúȯ
  • portal circulation
    ¹®¸Æ¼øÈ¯
  • prevalence
    À¯Çà, ¿ì¼¼, À¯º´·ü, ÀÌȯÀ²
  • projector
    ÇÁ·ÎÁ§ÅÍ, ¿µ»ç±â, ȯµî±â
  • PSTN [=public switched telephone network]
    °øÁßÀüÈ­¸Á, °øÁßÀüÈ­±³È¯¸Á
  • pulmonary circulation
    Æó¼øÈ¯
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • B94.8
    Sequelae of other specified infectious and parasitic
    ±âŸ ¸í½ÃµÈ °¨¿°¼º ¹× ±â»ýÃæ¼º ÁúȯÀÇ ÈÄÀ¯Áõ
  • B94.9
    Sequelae of unspecified infectious or parasitic disease
    »ó¼¼ºÒ¸íÀÇ °¨¿°¼º ¶Ç´Â ±â»ýÃæ¼º ÁúȯÀÇ ÈÄÀ¯Áõ
  • B95
    Streptococcus and staphylococcus as the cause of diseases classified to other chapters
    ´Ù¸¥ Àå¿¡¼­ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼­ÀÇ »ç½½¾Ë±Õ ¹× Æ÷µµ¾Ë±Õ
  • B95.0
    Streptococcus, group A, as the cause of diseases classified to other chapters
    ´Ù¸¥ Àå¿¡¼­ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼­ÀÇ »ç½½¾Ë±Õ AÇ÷û±º
  • B95.1
    Streptococcus, group B, as the cause of diseases classified to other chapters
    ´Ù¸¥ Àå¿¡¼­ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼­ÀÇ »ç½½¾Ë±Õ BÇ÷û±º
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • conversion disorder
    Àüȯ Àå¾Ö
    1. ±âÁúÀû ÁúȯÀÌ ¾øÀÌ ¹«ÀǽÄÀûÀÎ ¿ä±¸³ª °¥µîÀ¸·Î ÀÎÇÑ °¨°¢À̳ª ¿îµ¿ ±â´ÉÀÇ Àå¾Ö°¡ Ư¡ÀÎ Á¤½Å Áúȯ. 2. ½Å°æÇÐÀû ¶Ç´Â ³»°úÀû ÁúȯÀÌ ¾øÀÌ ¸¶ºñ, ½Ã·Â »ó½Ç, ÇÔ±¸Áõ
  • conversion factor
    º¯È¯ °è¼ö
  • conversion rate
    ÀüȯÀ²
  • convertase
    Àüȯ È¿¼Ò
  • converting enzyme
    Àüȯ È¿¼Ò
  • coronary risk factor
    °ü»ó µ¿¸Æ Áúȯ À§Çè ¿äÀÎ
  • corpus epididymidis
    ºÎ°íȯ ¸öÅë, ºÎ°íȯü
  • counter-poise
    ġȯÀÇ
  • cremasteric artery
    °íȯ ¿Ã¸²±Ù µ¿¸Æ
  • cricothyroid muscle
    À±»ó °©»ó±Ù, ȯ»ó °©»ó±Ù
    ȯ»ó ¿¬°ñ Àü¸é¿¡¼­ ½ÃÀÛÇÏ¿© °©»ó ¿¬°ñ ÇÏ¿¬¿¡ ºÎÂøÇϸç, ÀÌ ±ÙÀ°ÀÌ ¼öÃàÇÏ¸é °©»ó ¿¬°ñÀ» ÀüÇϹæÀ¸·Î ȸÀü½ÃÄÑ ¼º´ëÀÇ ±äÀåµµ¸¦ Áõ°¡½ÃŲ´Ù.
  • Crohn's disease
    Crohn Áúȯ, Å©·Ð¾¾ º´, Å©·Ð º´
    Å©·ÐÀÌ 1932³â óÀ½À¸·Î ȸÀå ¸»´ÜÀÇ Àå¿°À» ±¹ÇÑÀû ȸÀå¿°À¸·Î ±âÀçÇÑ °Í. ȸÀå ¸»´Ü¿°. ¼ÒÀå, ´ëÀå¿¡¼­µµ º¼ ¼ö ÀÖÀ¸¸ç ȸÀå ¸»´ÜºÎÀÇ °ÅÀÇ 30cm¿¡ ÀÚÁÖ ¹ß»ýÇϰí Á¡¸·¿¡¼­ Á¡¸· ÇÏÃþ¿¡ ¹ÌÄ¡´Â ¿°Áõ¼º º¯È­·Î À°¾Æ °Å´ë¼¼Æ÷¸¦ º¼ ¼ö ÀÖ´Ù. ¿øÀÎÀº Àå³» ¼¼±Õ, ¾Ë·¯Áö µîÀÇ ¿¬°üµÈ °ÍÀ¸·Î º¸ÀδÙ.
  • cryptorchidectomy
    Àẹ °íȯ ÀýÁ¦
    Á¤·ù °íȯÀ» ÀûÃâ Á¦°ÅÇÏ´Â °Í.
  • cyclarthrosis
    Â÷Ãà °üÀý, Â÷Ãà ȯ»ó °üÀý
    ȸÀüÇÒ ¼ö ÀÖ´Â °üÀý.
  • cycle
    ÁÖ±â, ¼øÈ¯, Á֯ļö, »çÀÌŬ, Ç츣Âê, ¼øÈ¯ °úÁ¤, ȸ·Î
    »ç°ÇÀ̳ª Áõ»óÀÇ ¿¬¼Ó. °üÃøµÇ´Â Çö»óÀÇ Àϼø, ¶Ç´Â ¿¬¼Ó. º¸ÅëÀº ±ÔÄ¢ÀûÀÎ °£°Ý°ú µ¿ÀÏÇÑ ¼ø¼­·Î ¹Ýº¹µÈ´Ù.
  • cyclic
    Áֱ⼺, ÁÖ±âÀÇ, Áֱ⼺ÀÇ, ¼øÈ¯ÀÇ, °í¸®ÀÇ
    Áֱ⼺ÀÇ, ¼øÈ¯ÀÇ, ȯ»óÀÇ. ÀÌ ¿ë¾î´Â ¿øÀÚÀÇ °í¸®¸¦ ÇÔÀ¯ÇÑ È­ÇÕ¹°¿¡ ´ëÇÏ¿© »ç¿ëµÈ´Ù.
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ȯÀÎź»ê¸®Æ¬Á¤ - »õâ
ȯÀÎÁ¦¾à
A09701651 Lithium carbonate
Àü¹®ÀǾàǰ | ±Þ¿©
·Î¶ó¹ÝÁ¤1mg - »õâ
ȯÀÎÁ¦¾à
G01000241 Lorazepam
Àü¹®ÀǾàǰ | ±Þ¿©
·Î¶ó¹ÝÁ¤0.5mg - »õâ
ȯÀÎÁ¦¾à
G01000261 Lorazepam
Àü¹®ÀǾàǰ | ±Þ¿©
´º¸¶±×Á¤ - »õâ
ȯÀÎÁ¦¾à
A09750211 Magnesium Lactate, Pyridoxine HCl
ÀϹÝÀǾàǰ | ±Þ¿©
¾Æ´Ï½ºÆ¾Á¤ - »õâ
ȯÀÎÁ¦¾à
A09702431 Mequitazine
Àü¹®ÀǾàǰ | ±Þ¿©
Æä´ÏµåÁ¤10mg - »õâ
ȯÀÎÁ¦¾à
G01000341 Methylphenidate HCl
Àü¹®ÀǾàǰ | ±Þ¿©
Æä´ÏµåÁ¤5mg - »õâ
ȯÀÎÁ¦¾à
G01000331 Methylphenidate HCl
Àü¹®ÀǾàǰ | ±Þ¿©
ȯÀγª·Ï¼ÕÁÖ2mg - »õâ
ȯÀÎÁ¦¾à
A09702061 Naloxone HCl
Àü¹®ÀǾàǰ | »èÁ¦
ȯÀγª·Ï¼ÕÁÖ - »õâ
ȯÀÎÁ¦¾à
A09701551 Naloxone HCl
Àü¹®ÀǾàǰ | »èÁ¦
¾Æ³«½ºÁ¤ - »õâ
ȯÀÎÁ¦¾à
A09701961 Naproxen sodium
ÀϹÝÀǾàǰ | ±Þ¿©
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • fantasy
    ȯ»ó
  • phantasm
    ȯ»ó
  • reverie
    ȯ»ó
  • reverie
    ȯ»ó;¸ù»ó;¸Á»ó;ȯ»ó°î
  • fantast
    ȯ»ó°¡;¸ù»ó°¡
  • fantasist
    ȯ»ó°î(ȯ»óÀû ÀÛǰ)À» ¾²´Â ÀÛ°î°¡(ÀÛ°¡);¸ù»ó°¡
  • fantasia
    ȯ»ó°î;È¥¼º°î
  • loop line
    ȯ»ó¼±
  • illusionsm
    ȯ»ó¼³,¹Ì¸Á¼³(½ÇÀç ¼¼°è´Â ÇϳªÀÇ È¯¿µÀ̶ó°í ÇÏ´Â);ȯ°¢¹ý Ì´
  • visioned
    ȯ»ó¿¡ ³ªÅ¸³­;ȯ¿µ¿¡ ÀÇÇÑ;»ó»ó·Â(ÅëÂû·Â)ÀÌ Ç³ºÎÇÑ
  • visional
    ȯ»óÀ¸·Î º»;Çã±úºñ(°îµÎ)ÀÇ;ȯ¿µÀÇ;ȯ¿µÀûÀÎ;¸ù»óÀûÀÎ;°¡°øÀÇ
  • annuloid
    ȯ»óÀÇ
  • LinuX
    ȯ»óÀÇ 32ºñÆ® ¿î¿µÃ¼Á¦;¾²¸é ¾µ¼ö·Ï ±× ÆÄ¿ö¿¡ ºüÁ®µé°ÍÀÌ´Ù. ´À²¸º¸¶ó ¸®´ª½ºÀÇ ÆÄ¿ö~
  • magic realism
    ȯ»óÀû »ç½ÇÁÖÀÇ
  • fantasticate
    ȯ»óÀûÀ¸·Î ÇÏ´Ù
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • stonehenge
    ȯ¿­¼®ÁÖ
  • subpena
    ¼ÒȯÀå
  • subpoena
    ¼ÒȯÇÏ´Ù
  • swap
    ±³È¯ÇÏ´Ù
  • trance
    ¸ùȯÀǰæÁö,ȲȦ,³ÌÀ»ÀÒ°í,½Ç½Å,ÀλçºÒ¼º,È¥¼ö»óÅÂ,½Ç½ÅÇÏ´Ù
  • transpose
    ¼­·Î ¹Ù²ã³õ´Ù; ÀüȯÇÏ´Ù
  • transposition
    Àüȯ
  • turn in
    Á¦ÃâÇÏ´Ù; Á¢´Ù; ¹ÝȯÇÏ´Ù
  • ventilate
    ȯ±â¸¦ ÇÏ´Ù
  • ventilation
    ȯ±â
  • ventilator
    ȯ±âÀåÄ¡
  • visionary
    ȯ¿µÀÇ; °¡°øÀûÀÎ
  • welcome
    ȯ¿µ¹Þ´Â
  • Aegisthus
    ¾ÆÀ̱⽺Ʈ½º(AgamemnonÀÇ ¾Æ³»¸¦ À¯È¤Çϰí,±ÍȯÇÑ ±×¸¦ »ìÇØ,³ªÁß¿¡ ±×ÀÇ ¾Æµé Orestes¿¡°Ô »ìÇØµÊ)
  • Annelida
    ȯÇü µ¿¹°¹®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÅëÇÕ°Ë»ö ¿Ï·á